Study

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome

The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and…

Ryan has been a financial writer for more than a decade, covering…

In a recent YouTube video, host Ryan of the Independent Investor channel…

Basic to Translational Science That Supports Development of Its Proprietary…

VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) — LEEF Brands Inc.…

The cycle of investment in tech startups generally follows certain patterns. The…